# Bright Minds Biosciences Inc.: Form 6-K, filed Nov 2, 2026

- Company: [Bright Minds Biosciences Inc.](/companies/drug.md) (CIK 1827401)
- Form: 6-K
- Filed: 2026-11-02
- Accepted by EDGAR: Nov 2, 2026, 16:30 ET
- Period: 2026-11-02
- Accession: 0002060755-26-000063
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1827401/000206075526000063/f6k-20261102drug.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1827401/000206075526000063/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1827401/000206075526000063/f6k-20261102drug.htm

Filed Nov 2, 2026.
Source: SEC EDGAR, the filing index for accession 0002060755-26-000063. Last ingested by Listed: Nov 2, 2026, 18:24 ET. No prices; not investment advice.
